Tuesday, February 10, 2009

Court Report

About Court Report: Each week http://www.patentdocs.org/ report briefly on recently filed biotech and pharma cases, and they select few interesting cases for periodic monitoring.

Boehringer Ingelheim Vetmedica Inc. v. Merial Ltd. et al.3:09-cv-00212; filed February 4, 2009 in the District Court of Connecticut (porcine circovirus vaccines)

Alcon Research, Ltd. et al. v. Apotex Inc. et al.1:09-cv-00102; filed February 2, 2009 in the Southern District of Indiana &
Alcon Research, Ltd. et al. v. Sandoz Inc.1:09-cv-00103; filed February 2, 2009 in the Southern District of Indiana (olopatadine hydrochloride ophthalmic solution, used to treat ocular itching associated with allergic conjunctivitis)

Cephalon Inc. et al. v. Barr Pharmaceuticals Inc. et al.1:09-cv-00074; filed January 30, 2009 in the District Court of Delaware (fentanyl citrate buccal tablets, used to treat breakthrough pain in adult patients with cancer)

Warner Chilcott Laboratories Ireland Ltd. et al. v. Actavis Elizabeth LLC et al.2:09-cv-00469; filed January 30, 2009 in the District Court of New Jersey (modified release doxycycline hyclate, used for adjunctive treatment of severe acne)

Eli Lilly & Co. v. Invagen Pharmaceuticals, Inc.2:09-cv-00392; filed January 29, 2009 in the Eastern District of New York (raloxifene)

Boehringer Ingelheim International GmBH et al. v. Mylan Pharmeceuticals Inc. et al.2:09-cv-00366; filed January 26, 2009 in the District Court of New Jersey (pramipexole dihydrochloride)

The details of the complaints can be read here.

No comments: